Nephrotoxicity of amikacin in noncritically ill patients
.
Sign Up to like & getrecommendations! Published in 2019 at "Clinical nephrology"
DOI: 10.5414/cn109761
Abstract: AIMS Several studies have reported that critically ill patients who require amikacin for the treatment of severe infection require therapeutic drug monitoring (TDM) to prevent acute kidney injury. Moreover, studies so far have mainly focused… read more here.
Keywords: ill patients; noncritically ill; nephrotoxicity; amikacin noncritically ... See more keywords